Pro-Dex, Inc. (NASDAQ: PDEX) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $198M. The Maz Rating grades it against the other companies in its sector.
Pro-Dex, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $61.93, Pro-Dex, Inc. trades at 16.6x trailing earnings, 2.5x sales and 4.0x book value, with an EV/EBITDA of 12.0. Over the last twelve months it generated about $80M of revenue and $12M of net income. It runs a gross margin of 32.5%, an operating margin of 16.8% and a net margin of 15.1%. It shows return on equity of 26.2%, return on invested capital of 15.5% and a free cash flow yield of 5.5%. On the balance sheet: a debt-to-equity ratio of 0.38 and a current ratio of 4.19. Over the past 52 weeks the share price ranged from $28.81 to $77.00, with a beta of 0.06.
Pro-Dex, Inc. does not currently pay a dividend.
1 Wall Street analyst rating covers the stock: 1 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical drivers and shavers, available in both battery-powered and electric models, often equipped with multi-functional capabilities. These instruments are primarily employed in orthopedic, thoracic, and craniomaxillofacial surgical procedures. Beyond its core manufacturing, Pro-Dex also offers expert consulting services, covering engineering, quality assurance, and regulatory compliance. Furthermore, the company manufactures and distributes rotary air motors to various industrial clients. Founded in 1978, Pro-Dex, Inc. maintains its corporate headquarters in Irvine, California.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, Pro-Dex, Inc. (PDEX) passes 4 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global, Dow Jones and MSCI, and fails FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 8.09% / 30% · (Cash+Inv) / Mkt Cap (36m) 6.46% / 30% · Interest income / Revenue 0.25% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 8.09% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 6.22% / 33% · Receivables / Mkt Cap (36m) 8.90% / 49% · Interest income / Revenue 0.25% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 8.09% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 6.22% / 33.33% · Receivables / Mkt Cap (24m) 8.90% / 33.33% · Interest income / Revenue 0.25% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 22.6% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 14.6% / 33.33% · Receivables / Avg Assets (4Q) 27.0% / 33.33% · Interest income / Revenue 0.25% / 5% | Pass |
| FTSE | Debt / Total Assets 22.1% / 33.33% · (Cash+ST Inv) / Total Assets 17.0% / 33.33% · (Cash+Recv) / Total Assets 41.2% / 33.33% · Interest income / Revenue 0.25% / 5% | Fail |
It depends on the standard you follow. As of September 2026, Pro-Dex, Inc. (PDEX) passes 4 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global, Dow Jones and MSCI, and fails FTSE.
Yes. Pro-Dex, Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 0.25% of each dividend: Pro-Dex, Inc.'s interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q1 2027). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.